MDS Selects BioMérieux to Fully Automate Eight Labs

BioMérieux announced it has secured a five-year contract with MDS Diagnostic Services, a provider of laboratory testing services in Canada, to supply its VITEK 2 automated bacteriology identification and susceptibility testing system to eight MDS laboratories in British Columbia and Ontario, Canada.

VITEK 2 provides rapid results processing (a two- to six-hour average turnaround), which enables MDS to provide timely and accurate test results to the more than 21,000 healthcare providers and 17 million patients it serves annually.

The system is a fully automated bacterial identification and antibiotic susceptibility testing system. The system also includes a highly advanced software system that then interprets the identified bacteria's antibiotic resistance patterns. Additionally, the company has designed a unique, 64-well susceptibility card specifically for MDS to further enhance productivity on their VITEK 2 instruments.